Hirokuni Uchida

901 total citations
10 papers, 757 citations indexed

About

Hirokuni Uchida is a scholar working on Molecular Biology, Biomaterials and Genetics. According to data from OpenAlex, Hirokuni Uchida has authored 10 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 2 papers in Biomaterials and 2 papers in Genetics. Recurrent topics in Hirokuni Uchida's work include RNA Interference and Gene Delivery (9 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Nanoparticle-Based Drug Delivery (2 papers). Hirokuni Uchida is often cited by papers focused on RNA Interference and Gene Delivery (9 papers), Advanced biosensing and bioanalysis techniques (7 papers) and Nanoparticle-Based Drug Delivery (2 papers). Hirokuni Uchida collaborates with scholars based in Japan, Australia and China. Hirokuni Uchida's co-authors include Kazunori Kataoka, Keiji Itaka, Takehiko Ishii, Kanjiro Miyata, Nobuhiro Nishiyama, Tomoya Suma, Satoshi Uchida, Makoto Oba, Kensuke Osada and Shigeto Fukushima and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Biomaterials.

In The Last Decade

Hirokuni Uchida

10 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hirokuni Uchida Japan 9 614 182 143 68 52 10 757
Charlie Yu Ming Hsu Canada 12 507 0.8× 161 0.9× 66 0.5× 108 1.6× 65 1.3× 16 682
Sang-oh Han United States 14 648 1.1× 309 1.7× 73 0.5× 66 1.0× 58 1.1× 27 896
Weidan Peng United States 15 625 1.0× 229 1.3× 127 0.9× 93 1.4× 23 0.4× 28 938
Leonardus J. van der Aa Netherlands 11 350 0.6× 71 0.4× 269 1.9× 185 2.7× 35 0.7× 13 741
Yong Serk Park South Korea 16 555 0.9× 113 0.6× 235 1.6× 202 3.0× 35 0.7× 38 903
Meredith A. Jackson United States 11 424 0.7× 44 0.2× 127 0.9× 113 1.7× 77 1.5× 12 608
Kyosuke Yamauchi Japan 4 308 0.5× 100 0.5× 100 0.7× 51 0.8× 11 0.2× 4 405
Kelli M. Luginbuhl United States 10 373 0.6× 160 0.9× 243 1.7× 94 1.4× 8 0.2× 12 686
Maria Jakobsen Denmark 11 369 0.6× 162 0.9× 68 0.5× 45 0.7× 23 0.4× 14 513
Pu Shi United States 11 214 0.3× 183 1.0× 206 1.4× 70 1.0× 17 0.3× 12 543

Countries citing papers authored by Hirokuni Uchida

Since Specialization
Citations

This map shows the geographic impact of Hirokuni Uchida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirokuni Uchida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirokuni Uchida more than expected).

Fields of papers citing papers by Hirokuni Uchida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirokuni Uchida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirokuni Uchida. The network helps show where Hirokuni Uchida may publish in the future.

Co-authorship network of co-authors of Hirokuni Uchida

This figure shows the co-authorship network connecting the top 25 collaborators of Hirokuni Uchida. A scholar is included among the top collaborators of Hirokuni Uchida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirokuni Uchida. Hirokuni Uchida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Itaka, Keiji, Hirokuni Uchida, Satoshi Uchida, et al.. (2016). Messenger RNA delivery of a cartilage-anabolic transcription factor as a disease-modifying strategy for osteoarthritis treatment. Scientific Reports. 6(1). 18743–18743. 99 indexed citations
2.
Uchida, Satoshi, Hiroaki Kinoh, Takehiko Ishii, et al.. (2016). 593. Anti-Angiogenic Therapy for Pancreatic Cancer by Systemic Delivery of Messenger RNA Using Polyplex Nano Micelle. Molecular Therapy. 24. S234–S235. 1 indexed citations
3.
Uchida, Hirokuni, Keiji Itaka, Satoshi Uchida, et al.. (2016). Synthetic Polyamines to Regulate mRNA Translation through the Preservative Binding of Eukaryotic Initiation Factor 4E to the Cap Structure. Journal of the American Chemical Society. 138(5). 1478–1481. 34 indexed citations
4.
Uchida, Satoshi, Hiroaki Kinoh, Takehiko Ishii, et al.. (2015). Systemic delivery of messenger RNA for the treatment of pancreatic cancer using polyplex nanomicelles with a cholesterol moiety. Biomaterials. 82. 221–228. 126 indexed citations
5.
Gao, Hui, Hiroyasu Takemoto, Qixian Chen, et al.. (2015). Regulated protonation of polyaspartamide derivatives bearing repeated aminoethylene side chains for efficient intracellular siRNA delivery with minimal cytotoxicity. Chemical Communications. 51(15). 3158–3161. 17 indexed citations
6.
Uchida, Hirokuni, Keiji Itaka, Takahiro Nomoto, et al.. (2014). Modulated Protonation of Side Chain Aminoethylene Repeats in N-Substituted Polyaspartamides Promotes mRNA Transfection. Journal of the American Chemical Society. 136(35). 12396–12405. 121 indexed citations
7.
Uchida, Satoshi, Keiji Itaka, Hirokuni Uchida, et al.. (2013). In Vivo Messenger RNA Introduction into the Central Nervous System Using Polyplex Nanomicelle. PLoS ONE. 8(2). e56220–e56220. 99 indexed citations
8.
9.
Uchida, Hirokuni, Kanjiro Miyata, Makoto Oba, et al.. (2011). Odd–Even Effect of Repeating Aminoethylene Units in the Side Chain of N-Substituted Polyaspartamides on Gene Transfection Profiles. Journal of the American Chemical Society. 133(39). 15524–15532. 180 indexed citations
10.
Yanagië, Hironobu, Takenori Takahashi, Taisuke Tomita, et al.. (1989). [Boron neutron capture therapy using 10B entrapped anti-CEA immunoliposome].. PubMed. 2(3). 290–6. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charlie Yu Ming Hsu Breakdown of academic impact, for papers by Sang-oh Han Breakdown of academic impact, for papers by Weidan Peng Breakdown of academic impact, for papers by Leonardus J. van der Aa Breakdown of academic impact, for papers by Yong Serk Park Breakdown of academic impact, for papers by Meredith A. Jackson Breakdown of academic impact, for papers by Kyosuke Yamauchi Breakdown of academic impact, for papers by Kelli M. Luginbuhl Breakdown of academic impact, for papers by Maria Jakobsen Breakdown of academic impact, for papers by Pu Shi
Rankless by CCL
2026